REMEDY : BNSSG referral pathways & Joint Formulary


Home > Adults > Diabetes >

Non-diabetic Hyperglycaemia and the National Diabetes Prevention Program

Checked: 21-05-2023 by Vicky Ryan Next Review: 21-05-2024

Service Overview

Non-diabetic Hyperglycaemia

An HbA1c of between 42.0 and 47.9 mmol/mol indicates patients are at high risk of diabetes and can be considered to have Non-diabetic Hyperglycaema (this is now the preferred term - previously known as Pre-diabetes/ Impaired fasting glycaemia.)

Evidence suggests that Type 2 DM can be prevented or onset delayed if patients at risk are identified and make lifestyle changes.

Patients identified should be offered an annual check in practice to include HbA1c and vascular risk assessment, have weight/BMI assessed at least once a year and have lifestyle reviewed annually.

National Diabetes Prevention Program

NHS England fund the NHS Diabetes Prevention Programme (NDPP) 

The provider of the NDPP across BNSSG from 1/7/2022 is Living Well Taking Control (LWTC). You can find out more information about the NDPP and LWTC on their website and TeamNet.

You can also find full details in the Healthier You NHS Diabetes Prevention Programme: BNSSG Toolkit

All GP practices are able to refer eligible patients into the NDPP, and it is recommended that all eligible patients are referred.

Eligibility criteria

When referred by a Healthcare Professional

  • HbA1c between 42.0 and 47.9 mmol/mol or FPG of 5.5 – 6.9 mmol/l within past 12 months
  • No previous Type 2 diabetes diagnosis
  • Aged 18+ and registered with a GP in BNSSG area
  • Not pregnant

Patients with a past history of Gestational Diabetes can also be referred with normal-range blood glucose results. Eligible range blood glucose results for a patient with past diagnoses of GDM are Hba1c <47.9mmol/mol or FPG <6.9 mmol/l.

For more information about the NHS Diabetes Prevention Programme, please email: r.botha@lwtcsupport.co.uk

EMIS Resources:

The following EMIS resources have been created to support GP practices in referring eligible patients into the Living Well Taking Control NHS DPP;

  • EMIS search, Clinical template, Referral form and Patient Invitation letter.

Referral

When a diagnosis of Non-diabetic Hyperglycaemia is made, then patients should have this coded on their medical record.

Self -Referral

Patients can self-refer using the referral link REGISTER | diabetes-prevention (lwtcsupport.co.uk) .They must have the following information available:

  • HbA1c result
  • Date of HbA1c test
  • NHS number
  • Name of GP surgery

There is also a letter (available in EMIS) that can be issued to the patient that includes this information and the link. 

Practice Referral

For the practice to make a referral, generate the LWTC NHS DPP referral form in EMIS as follows:

  1. Use the CCG LWTC NHS DPP Template (High risk Diabetes)_2022 template (it should come up as an option if you search 'NDPP' or 'diabetes'.)
  2. Once in the template, tick the box 'Referral to NHS Diabetes Prevention Programme'.
  3. On saving the template a pop up should appear 'Living Well Taking Control referral form will now launch'. On clicking ok, a pre-populated referral from will be generated.
  4. Complete the referral form and once saved send the referral to hex.ndpp.bnssg@nhs.net
  5. You are then given the choice to send a patient invitation letter yourself or create a task for the medical secretaires to send out.


Efforts are made to ensure the accuracy and agreement of these guidelines, including any content uploaded, referred to or linked to from the system. However, BNSSG ICB cannot guarantee this. This guidance does not override the individual responsibility of healthcare professionals to make decisions appropriate to the circumstances of the individual patient, in consultation with the patient and/or guardian or carer, in accordance with the mental capacity act, and informed by the summary of product characteristics of any drugs they are considering. Practitioners are required to perform their duties in accordance with the law and their regulators and nothing in this guidance should be interpreted in a way that would be inconsistent with compliance with those duties.

Information provided through Remedy is continually updated so please be aware any printed copies may quickly become out of date.